Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerAimery de Gramont, Andrea Bonetti, Arié Figer et al.|Journal of Clinical Oncology|2000Cited by 3.8k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung CancerAlexander Drilon, Vivek Subbiah, Geoffrey R. Oxnard et al.|New England Journal of Medicine|2020Cited by 835
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasYuchen Jiao, Laura D. Wood, Timothy M. Pawlik et al.|Nature Genetics|2013Cited by 709
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trialsAlexander Drilon, Robert C. Doebele, Salvatore Siena et al.|The Lancet Oncology|2019Cited by 537
Fasting-mimicking diet and hormone therapy induce breast cancer regressionIrene Caffa, Alessio Nencioni, V. Spagnolo et al.|Nature|2020Cited by 361